HINDBIO.BO
Get informed when a big investor buys or sells
+ Follow| Market cap | $76.37 Million |
|---|---|
| Enterprise Value | $76.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | -0.7 |
| Outstanding Shares | 10,250,800 |
| P/E Ratio | -37.8 |
|---|---|
| PEG | 4.17 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 19.97 |
| Enterprise Value to EBIT | -34.17 |
| Enterprise Value to Net Income | -38 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Hindustan Bio Sciences Ltd. specializes in the trade of pharmaceuticals and medical supplies. Its extensive product catalog encompasses liquid injectables, various liquid and dry syrups, ophthalmic, otic, and nasal drops, and pre-filled ...